The weekly litigation news digest is live. Subscribe now

IP Verse

Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof - EP4357457

The patent EP4357457 was granted to Toolgen Incorporated on Oct 16, 2024. The application was originally filed on Oct 23, 2013 under application number EP24158339A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4357457

TOOLGEN INCORPORATED
Application Number
EP24158339A
Filing Date
Oct 23, 2013
Status
Granted And Under Opposition
Sep 13, 2024
Publication Date
Oct 16, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GRUND GROUP PATENTANWALTE UND SOLICITOR PARTG MBBMar 6, 2025GRUNDADMISSIBLE
VERTEX PHARMACEUTICALS INCORPORATEDFeb 28, 2025CARPMAELS & RANSFORDADMISSIBLE
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBOct 16, 2024-ADMISSIBLE

Patent Citations (3) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONWO2014093595
SEARCHWO2010076939
SEARCHWO2013176772

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents